Skip to main content

Biopharma Startups

Updated October 2026

Companies in the biopharma sector developing innovative solutions and technologies.

Explore 906 recently funded biopharma companies with verified founder contact information and fundraising data.

Total Companies
906
Total Funding
$689.1M
Avg Funding
$27.6M
Global Reach
6
countries

Top Cities for Biopharma

San Mateo
Palo Alto
Paramus
South San Francisco
San Diego
Seattle

Recently Funded Companies

Export
San Mateo, United States

Mahzi Therapeutics is a health care and biotechnology company.

$4.0M raised
May 2025

Founder Contacts

41,000+ verified contacts

Palo Alto, United States

Countable Labs provides a PCR system for single-molecule counting and high-sensitivity molecular detection in biotechnology.

$26.0M raised
May 2026

Founder Contacts

41,000+ verified contacts

Paramus, United States

Polaryx Therapeutics is a biopharmaceutical company that provides molecule therapeutics development and clinical trial services.

$10.0M raised
May 2026

Founder Contacts

41,000+ verified contacts

South San Francisco, United States

ORIC Pharmaceuticals is a biopharmaceutical company that develops treatments that target the causes of therapeutic resistance.

$125.0M raised
May 2025

Founder Contacts

41,000+ verified contacts

San Diego, United States

ClearNote Health delivers epigenomic and big data approaches to reinvent non-invasive molecular diagnostic testing.

$52.0M raised
May 2026

Founder Contacts

41,000+ verified contacts

Seattle, United States

Aptevo Therapeutics is a biotech company primarily focused on bringing novel oncology and hematology therapeutics to market.

May 2026

Founder Contacts

41,000+ verified contacts

Los Angeles, United States

Ember LifeSciences is a healthcare technology company that develops cold chain solutions for transporting temperature-sensitive medicines.

May 2026

Founder Contacts

41,000+ verified contacts

San Carlos, United States

Protuoso Biosciences develops next-generation multifunctional biologics designed to address complex disease biology.

$9.5M raised
May 2026

Founder Contacts

41,000+ verified contacts

Bordeaux, France

TreeFrog Therapeutics is a stem cell company that will enable millions of patients to access the medical revolution of cell therapies.

$34.0M raised
May 2025

Founder Contacts

41,000+ verified contacts

London, United Kingdom

Perceptic develops modular AI software that supports scientific decision-making for biopharma research and external asset evaluation.

$12.0M raised
May 2026

Founder Contacts

41,000+ verified contacts

San Francisco, United States

Reprogram Biosciences is a biotechnology company that develops cancer treatment with cell reprogramming technology.

$5.0M raised
May 2026

Founder Contacts

41,000+ verified contacts

Nashville, United States

Amytrx Therapeutics is a biopharmaceutical company that advances the next generation of new anti-inflammatory peptide therapies.

$18.0M raised
May 2022

Founder Contacts

41,000+ verified contacts

Redwood City, United States

Retro Biosciences focuses on cellular reprogramming, autophagy, and plasma-inspired therapeutics.

May 2026

Founder Contacts

41,000+ verified contacts

San Francisco, United States

AbInitio Bio develops AI foundation models for biologic drug manufacturability and process optimization.

$500K raised
May 2026

Founder Contacts

41,000+ verified contacts

La Habra, United States

Oculogenex is a biopharmaceutical company that specializes in gene therapy for the treatment of retinal disorders.

$1.0M raised
May 2022

Founder Contacts

41,000+ verified contacts

Cincinnati, United States

NeutraNarc is an eco biotechnology company that offers biodegradable drug disposal chemicals and products.

$9.6M raised
May 2025

Founder Contacts

41,000+ verified contacts

Pittsburgh, United States

Krystal Biotech provide significant clinical benefit for patients suffering from rare debilitating disorders..

$160.0M raised
May 2023

Founder Contacts

41,000+ verified contacts

Saskatoon, Canada

ZYUS is a biopharmaceutical company that offers patients cannabinoid and other phyto-therapeutic medical solutions.

$505K raised
May 2026

Founder Contacts

41,000+ verified contacts

Salt Lake City, United States

Co-Diagnostics is a molecular diagnostics company that enhances the output of molecular diagnostic tests.

$3.0M raised
May 2026

Founder Contacts

41,000+ verified contacts

San Diego, United States

cAMPfield Therapeutics is a biotechnology company that specializes on exploration and development activities of therapeutic solutions.

$180.0M raised
May 2026

Founder Contacts

41,000+ verified contacts

New York, United States

Calder Biosciences is a groundbreaking biotechnology and molecular engineering firm developing next generation subunit vaccines

May 2025

Founder Contacts

41,000+ verified contacts

Basel, Switzerland

Encelta T-cell therapy target and eliminate both blood cancers and solid tumors combined with bispecific antibodies.

$1.7M raised
May 2025

Founder Contacts

41,000+ verified contacts

Morrisville, United States

Locus Biosciences develops CRISPR-engineered precision antibacterial platform designed to revolutionize the treatment of bacterial disease.

$35.0M raised
May 2022

Founder Contacts

41,000+ verified contacts

Auckland, New Zealand

Helico is a biopharma company that intends to make plants able to manufacture lifesaving medicine.

$1.3M raised
May 2022

Founder Contacts

41,000+ verified contacts

Solana Beach, United States

ClearPath Vascular is a healthcare company that offers technologies that can be used in neuro and peripheral vascular procedures.

$1.0M raised
May 2025

Founder Contacts

41,000+ verified contacts

Showing 276 to 300 of 906 companies

About the Biopharma Startup Ecosystem

The biopharma sector is an active area of startup innovation and venture capital investment. Companies in this space are developing new technologies, platforms, and services that address evolving market needs and create new business opportunities.

Funding Trends in Biopharma

Biopharma companies raise capital across various funding stages, from early seed rounds to late-stage growth financing. Investor interest in this sector is driven by the size of the addressable market, the pace of technology adoption, and the potential for scalable business models.

Growth Outlook

The biopharma sector is expected to continue evolving as technology advances, market dynamics shift, and new opportunities emerge. Companies that demonstrate strong product-market fit, efficient growth, and clear competitive advantages are well-positioned to attract continued investment.

Biopharma Funding Breakdown

Here is how funding is distributed among the 906 biopharma companies tracked in the VCBacked database.

Average Funding
$27.6M
Total Funding Tracked
$689.1M
Countries Represented
6

Distribution by Funding Stage

Other25 companies

Top Cities for Biopharma

1.San Diego
2 companies$232.0M
2.San Francisco
2 companies$5.5M
3.San Mateo
1 companies$4.0M
4.Palo Alto
1 companies$26.0M
5.Paramus
1 companies$10.0M

Related Industries

Companies in the biopharma sector often overlap with or complement businesses in adjacent industries. Exploring related verticals can help you discover additional companies, identify partnership opportunities, and understand the broader competitive landscape.

Ready to Connect with Biopharma Startups?

Perfect for: B2B sales teams targeting biopharma companies, investors exploring sector opportunities, and service providers looking for funded companies ready to scale.

Get Started - Access Contact Information

Join thousands of sales teams, investors, and service providers using VCBacked